A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

Profiles >> Frieda Hernandez Archives

Patient-Powered Collaboration: ALD Connect Launches a Doctor-Patient Webinar Series

Posted by | 3:14pm on Wednesday, November 5, 2014 | No Comments

The ALD Connect website offers a great video that explains ALD 

As part of our ongoing focus on multi-stakeholder collaboration in the rare disease space, we are highlighting successful and unique examples of this programming to improve patient outcomes. ALD Connect is a Patient-Powered Research Network (PPRN) consortium composed of ALD patients, patient advocates, and researchers supported in part by the Patient-Centered Outcomes Research Institute (PCORI). The mission of the organization is to improve health outcomes for patients with X-linked adrenoleukodystrophy (ALD) by empowering patients, raising awareness, and accelerating the translation of scientific advances into better clinical care.

ALD Connect’s Impressive Track Record
ALD Connect is a model of what can be accomplished when patient advocacy groups, academic researchers and physicians, and biopharmaceutical companies work together to accomplish their goals. Ben Lenail, a founder of the organization, was diagnosed in his 40s with adrenomyeloneuropathy (AMN), a late-onset phenotype of ALD. Frustrated by the lack of knowledge and options he was confronted with, Ben leveraged his own 25 years of technology and start-up experience to create ALD Connect to accelerate diagnosis and treatment of the disease and ultimately eradicate the debilitating single-gene disorder. Read More

Insights From a Patient Advocacy Summit

At the inaugural Global Genes Project 2012 Patient Advocacy Summit it was apparent that patient advocacy in the rare disease…



Why Doctors Are Often Stumped by Rare Disorders

PharmaPhorum asked Siren Interactive to write a series of blog posts about the world of rare diseases. In the six-part…


Crossing the Chasm of Pharma Social Media Adoption

At the end of last year, I predicted to anyone who would listen that we would cross the chasm of…



FDA Hearing on Social Media

Angela Romano, Content Intern at Siren Interactive, contributes this post: It finally happened — the FDA hearing on social media…


The Digital Pharma Revolution Was Definitely Twitterized!

Okay, so I appropriated that line from someone on Twitter who, probably unknowingly, mangled the great ’70s spoken word artist…


Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com